Hypertrophic cardiomyopathy (HC) patients are less active than the general U.S. population. More data are needed on exercise in HC to strike a balance between acute risks and long-term health benefits of exercise.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||